Aberrant N-cadherin expression has been observed in many cancer cell types (Nagi et al., 2005; Gravdal et al., 2007; Mrozik et al., 2018; Cao et al., 2019; Derynck and Weinberg 2019). This evidence concerns the gene CDH2 and cancer.